← Evidence map

ArticleNature2019

Patisiran's path to approval as an RNA therapy.

Carlos Heras-PalouPubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31619801